Manufacturer of pharmaceuticals with comprehensive product range, OSD or other pharmaceutical forms, such as sachets, suppositories, solutions for injections, infusions, suspensions and lyophilized powders. Therapeutic areas of interest include, cardiovascular, GI, diabetes, antivirals, CNS, oncology, respiratory, men and women health, children products or endocrinology. An established international distributor network and a focus on safety would be a plus.
Overview of this Buyer of European Pharmaceutical Manufacturer
This full-cycle production company was established over 20 years ago and now boasts a capacity of more than 750 million tablets, 87 million capsules and 11 million sachets per year at its two plants in Eastern Europe. A string of partnerships and in-licensing agreements with international partners have help built a product portfolio of over 350 SKUs, with another 150 products in R&D and registration.
Key therapeutic areas include lifestyle disease drugs, like cardiovascular or diabetes, plus more specialty product areas in oncology, CNS, respiratory or endocrinology.
Profile (strategy) of this Buyer of European Pharmaceutical Manufacturer
This pharmaceutical group has built a reputation for high quality production and as a reliable CMO partner for human health products. A growing network of international affiliates and external distributors complements its strong, decades-long manufacturing capabilities.
Recent initiatives to drive expansion have included in-licensing deals with international partners from the USA and other countries, and product distribution deals in Central America. The Group is also considering acquisitions in Europe.
The company is also open to explore product divestments, potential CMO work.
Activities and products of the target European Pharmaceutical Manufacturer
The group is most interested in similar pharmaceutical companies with a strong, diversified product portfolio and EU GMP. Preference is for a manufacturer of own products while CMO business would be valued also. Exports outside the EU are highly desirable.
Highlights of this Buyer of European Pharmaceutical Manufacturer
120€ million + Russian pharmaceutical group with strong brands
Targets sought with strong, diversified product portfolio
Manufacturing in EU a must
Buyer brings substantial manufacturing expertise
Buyer has established international partnership network across markets in the EU, Asia and the Americas
More information on this buyer of european pharmaceutical manufacturer